首页> 美国卫生研究院文献>Acta Pharmacologica Sinica >Mesenchymal stem cells: a new trend for cell therapy
【2h】

Mesenchymal stem cells: a new trend for cell therapy

机译:间充质干细胞:细胞治疗的新趋势

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mesenchymal stem cells (MSCs), the major stem cells for cell therapy, have been used in the clinic for approximately 10 years. From animal models to clinical trials, MSCs have afforded promise in the treatment of numerous diseases, mainly tissue injury and immune disorders. In this review, we summarize the recent opinions on methods, timing and cell sources for MSC administration in clinical applications, and provide an overview of mechanisms that are significant in MSC-mediated therapies. Although MSCs for cell therapy have been shown to be safe and effective, there are still challenges that need to be tackled before their wide application in the clinic.
机译:间充质干细胞(MSCs)是用于细胞治疗的主要干细胞,已经在临床中使用了大约10年。从动物模型到临床试验,MSC在治疗多种疾病(主要是组织损伤和免疫失调)方面具有广阔的前景。在这篇综述中,我们总结了有关在临床应用中MSC施用的方法,时间和细胞来源的最新观点,并概述了在MSC介导的治疗中重要的机制。尽管已经证明用于细胞治疗的MSC是安全有效的,但在将其广泛应用于临床之前,仍然需要解决一些挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号